Dow Up 1.06% Nasdaq Up 2.14%

BioTime, Inc. (BTX)

-NYSE MKT
3.29 Down 0.10(2.87%) 2:55PM EDT - Nasdaq Real Time Price
Prev Close:3.39
Open:3.40
Bid:3.29 x 400
Ask:3.30 x 300
1y Target Est:8.00
Beta:1.09
Next Earnings Date:N/A
Day's Range:3.27 - 3.36
52wk Range:2.21 - 4.18
Volume:51,971
Avg Vol (3m):246,126
Market Cap:220.18M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BTX

Comparison

Symbol% ChgMkt Cap
BTXDown 2.87%220.18M
BAXUp 1.00%37.17B
HSPUp 1.40%8.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioTime, Inc., a biotechnology company, is engaged in the research and product development in the field of regenerative medicine. The company primarily focuses on regenerative medicine, which refers to therapies based on human embryonic stem cell ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback